Patents

, (RNA Law)/ /Leave a comment

Brazil’s long-running effort to internalize drug manufacture through state-backed technology transfer agreements continues to face scrutiny. On May 7, 2025, the country’s Government Accountability Office (GAO) upheld its prior recommendation that the Ministry of Health (MOH) refrain from initiating new Partnerships for Productive Development (Parcerias para o Desenvolvimento Produtivo – PDPs) until it can demonstrate…

Brazil, Enforcement, Pharma

, , (RNA Law)/

The first Over-the-Counter Continuous Glucose Monitor (CGM) ever cleared in the United Stated by the FDA was launched by Dexcom. The Stelo Glucose Biosensor System (commercial name) has been cleared for anyone 18 years or older who does not use insulin (such as individuals with diabetes treating their condition with oral medications, or those without…